Supplementary Figure 8 from Identification of a Novel Inflamed Tumor Microenvironment Signature as a Predictive Biomarker of Bacillus Calmette-Guérin Immunotherapy in Non–Muscle-Invasive Bladder Cancer | Synapse
October 7, 2024Open Access
Supplementary Figure 8 from Identification of a Novel Inflamed Tumor Microenvironment Signature as a Predictive Biomarker of Bacillus Calmette-Guérin Immunotherapy in Non–Muscle-Invasive Bladder Cancer
Puntos clave
Los puntos clave no están disponibles para este artículo en este momento.
Resumen
Supplemental Figure 8 shows the relationship between the Fraction of Genome Altered by UROMOL subgroups within the MSK cohort.